bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

SA cancer test maker strikes deal with global medical device company

by Maria Zannes | Oct 19, 2020 | News

OCTOBER 15, 2020 As published in the San Antonio Business Journal By: W. Scott Bailey – Senior Reporter, San-Antonio Business Journal BioAffinity Technologies has teamed with a global medical device manufacturer, Smiths Medical, to expand the commercial reach...

Smiths Medical and bioAffinity Technologies Partner to Advance Non-Invasive Testing for Early Lung Cancer

by Maria Zannes | Oct 15, 2020 | Press Releases

Partnership supports patient care and sample collection for automated test demonstrating high accuracy in finding lung cancer FAQ: Answers to Questions about Cypath® Lung October 15, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company,...

bioAffinity Technologies Announces Dr. Martin Tammemägi to Chair Scientific and Medical Advisory Board

by Maria Zannes | Sep 29, 2020 | Press Releases

SEPTEMBER 29, 2020 (San Antonio, TX) FAQ: Answers to Questions about Cypath® Lung bioAffinity Technologies, a privately-held biotech company, today announced Martin Tammemägi, PhD, Professor Emeritus of Health Sciences at Brock University, will serve as Chairman of...

Inspirational Women Leaders of Tech: Maria Zannes of bioAffinity Technologies On The Five Things You Need To Know In Order To Create A Very Successful Tech Company

by Maria Zannes | Sep 26, 2020 | Articles, News

SEPTEMBER 26, 2020 By Douglas Brown, Authority Magazine Follow the science. Businesspeople rightfully seek to control a situation, but that does not bode well in the science field. Mother nature has a way of surprising you. Innovation is essential to a biotech...

BioAffinity Technologies CEO Maria Zannes talks cancer detection, women in medtech

by Maria Zannes | Sep 24, 2020 | Articles, Events, News

SEPTEMBER 24, 2020 Originally published in Medical Design & Outsourcing by Sean Whooley.   Maria Zannes and her company BioAffinity Technologies are seeking to up the game on lung cancer detection. Here’s how. Maria Zannes’ path to a leading role in the...
« Older Entries
Next Entries »

Categories

  • Articles (27)
  • Events (38)
  • News (52)
  • Press Releases (124)
  • Publications (17)

Recent Posts

  • bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board June 11, 2025
  • bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung June 3, 2025
  • bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics May 28, 2025
  • bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer May 20, 2025
  • bioAffinity Technologies Reports First Quarter 2025 Results May 15, 2025

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.